Related Experiment Video

Updated: Aug 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

The effect of TGFbeta1 on the expression and phosphorylation of key cell-cycle regulators in malignant B cells

Daniel Tvrdík1

  • 1Institute of Pathology, General Faculty Hospital, Prague, Czech Republic. daniel.tvrdikd@vfn.cz

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|November 30, 2004
PubMed
Abstract

Insights

Transforming growth factor beta1 (TGFbeta1) halts B cell growth by activating cyclin-dependent kinase (cdk) inhibitors. This mechanism leads to cell-cycle arrest in malignant non-Hodgkin

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor beta1 (TGFbeta1) is known to induce growth arrest in B lymphocytes.
  • This inhibitory action is mediated by deactivating kinase complexes.
  • Cyclin-dependent kinase (cdk) inhibitors control the cell cycle, mediating extracellular signals for cell-cycle arrest.

Purpose of the Study:

  • To investigate the effect of TGFbeta1 on cell-cycle regulators in a malignant B cell line.
  • To elucidate the molecular mechanisms underlying TGFbeta1-induced growth arrest in non-Hodgkin's lymphoma (NHL).

Main Methods:

  • Utilized the DoHH2 cell line, derived from a follicular origin malignant NHL patient.
  • Examined the expression and phosphorylation of cell-cycle regulators using immunoprecipitation and immunoblotting.
  • Analyzed the composition of cdk complexes and levels of cdk inhibitors.

Main Results:

  • TGFbeta1 treatment (10 ng/ml for 48 hours) significantly increased G0/G1 phase arrest in DoHH2 cells.
  • This arrest correlated with hypophosphorylation of pRb and increased levels of the cdk inhibitor p21(WAF1).
  • p21(WAF1) bound to cdk4/6, leading to cyclin D-cdk4/6 complex decomposition.

Conclusions:

  • TGFbeta1 induces growth arrest in malignant B cells of the follicular lymphoma subtype.
  • This growth arrest is associated with the activation of CIP/KIP family members of cdk inhibitors.
  • The findings provide insight into the role of TGFbeta1 signaling in NHL cell-cycle regulation.

More Related Videos

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...